Is Strides Pharma Science the Best Stock in Its Sector? A Look at the Numbers

Is Strides Pharma Science the best stock in its sector? The stock trades on the NSE at Rs 1,093 as of 12 October 2026, within its 52-week range of Rs 768.65 to Rs 1,260.90. Strides Pharma Science Ltd, headquartered in Bengaluru, makes and markets generic pharmaceutical formulations, with a significant presence in regulated markets such as the US.

Strides Pharma Science sits in the Healthcare sector, and its 17.90% ROE and 15.74x P/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector's Industry P/E benchmark.

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers

Click Here – Get Free Investment Predictions

About Strides Pharma Science

Strides Pharma Science Ltd, headquartered in Bengaluru, makes and markets generic pharmaceutical formulations, with a significant presence in regulated markets such as the US. Its products include oral solids, liquids and softgels supplied to regulated markets and institutional programmes. The stock trades about 13 percent below its 52-week high and about 42 percent above its 52-week low. At a market capitalisation of Rs 9,984 Cr, it is tracked as part of the Healthcare sector on Univest.

Is Strides Pharma Science the Best Stock in Its Sector?

Strides Pharma Science makes its case as the best stock in its sector primarily on valuation relative to its Industry P/E, combining a 17.90% ROE with a 15.74x P/E against the sector's 36.69x Industry P/E. Strides Pharma Science's 15.74x P/E is less than half the 36.69x Industry P/E and sits alongside a 17.90% ROE, though its generic business can be volatile and a 0.57 debt to equity ratio deserves attention.

Metric	Strides Pharma Science
CMP (NSE)	Rs 1,092.70
52-Week High / Low	Rs 1,260.90 / Rs 768.65
Market Cap	Rs 9,984 Cr
P/E (TTM) vs Industry P/E	15.74x vs 36.69x
P/B	3.21
ROE	17.90%
EPS (TTM)	Rs 68.83
Dividend Yield	0.46%
Debt to Equity	0.57

Compare Strides Pharma Science Against Other Healthcare Sector Stocks

How Strides Pharma Science Compares Against Its Healthcare Sector Peers

The table below sets Strides Pharma Science against 2 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P/E, ROE and debt to equity, calculated across the 2 peer companies.

Company	Market Cap (Rs Cr)	P/E	ROE	Debt to Equity
Strides Pharma Science	9,984	15.74	17.90%	0.57
Granules India	22,200	33.52	11.70%	0.30
Alembic Pharmaceuticals	15,746	22.83	11.89%	0.25
Peer average (2 companies)	-	28.18	11.79%	0.28

Against this peer set, Strides Pharma Science's 17.90% ROE is above the 11.79% peer average, and its P/E of 15.74x runs below the peer average of 28.18x. Strides Pharma Science's 15.74x P/E is less than half the 36.69x Industry P/E and sits alongside a 17.90% ROE, though its generic business can be volatile and a 0.57 debt to equity ratio deserves attention.

What Makes Strides Pharma Science Worth Watching in Healthcare

• Deep discount: A 15.74x P/E against a 36.69x Industry P/E is a wide gap to the sector benchmark.
• Return ratios: A 17.90% ROE shows decent profitability.
• Regulated markets: A presence in regulated markets such as the US widens the earnings base.

Strides Pharma Science Valuation: Is It Justified?

Strides Pharma Science's 15.74x P/E is less than half the 36.69x Industry P/E and sits alongside a 17.90% ROE, though its generic business can be volatile and a 0.57 debt to equity ratio deserves attention. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.

Also read – Is VIP Clothing the Best Stock in Its Sector? A Look at the Numbers

Download the Univest iOS App or Univest Android App to track Strides Pharma Science and other Healthcare sector stocks.

How to Track Strides Pharma Science Before You Invest

Before deciding whether Strides Pharma Science deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.

1. Open the Univest Screener and search for Strides Pharma Science to view live price, valuation ratios, and peer comparisons within the Healthcare sector.
2. Compare its P/E, P/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.
3. Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.
4. Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.

Conclusion

Strides Pharma Science earns a place in the best stock in its sector conversation on the strength of a 17.90% ROE and a P/E of 15.74x against a 36.69x Industry P/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.

Is Strides Pharma Science the best stock in its sector?

Ans. Strides Pharma Science has a 17.90% ROE and trades at 15.74x P/E against a 36.69x Industry P/E, and compares above the peer average ROE of 11.79% in this article's named comparison, so the answer depends on what an investor is prioritising.

What is the current share price of Strides Pharma Science?

Ans. Strides Pharma Science was trading at Rs 1,092.70 on the NSE as of 12 October 2026, within its 52-week range of Rs 768.65 to Rs 1,260.90.

What sector does Strides Pharma Science belong to?

Ans. Strides Pharma Science is classified under the Healthcare sector on Univest.

How does Strides Pharma Science compare to its sector peers on P/E?

Ans. Strides Pharma Science's P/E of 15.74x is below the 28.18x average of the 2 named peers compared in this article.

What is Strides Pharma Science's return on equity?

Ans. Strides Pharma Science reported a return on equity of 17.90%, which is above the 11.79% average of its named peers in this comparison.

Should I invest in Strides Pharma Science based on its sector position?

Ans. Strides Pharma Science's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.

{"@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [{"@type": "Question", "name": "Is Strides Pharma Science the best stock in its sector?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science has a 17.90% ROE and trades at 15.74x P/E against a 36.69x Industry P/E, and compares above the peer average ROE of 11.79% in this article's named comparison, so the answer depends on what an investor is prioritising."}}, {"@type": "Question", "name": "What is the current share price of Strides Pharma Science?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science was trading at Rs 1,092.70 on the NSE as of 12 October 2026, within its 52-week range of Rs 768.65 to Rs 1,260.90."}}, {"@type": "Question", "name": "What sector does Strides Pharma Science belong to?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science is classified under the Healthcare sector on Univest."}}, {"@type": "Question", "name": "How does Strides Pharma Science compare to its sector peers on P/E?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science's P/E of 15.74x is below the 28.18x average of the 2 named peers compared in this article."}}, {"@type": "Question", "name": "What is Strides Pharma Science's return on equity?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science reported a return on equity of 17.90%, which is above the 11.79% average of its named peers in this comparison."}}, {"@type": "Question", "name": "Should I invest in Strides Pharma Science based on its sector position?", "acceptedAnswer": {"@type": "Answer", "text": "Strides Pharma Science's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor."}}]}